Tag: DR.CI:LABO™

New data from DR.CI:LABO™ at IMCAS Asia 2025 reinforces leadership in adjunctive clinical skincare for daily and post-IPL care for Asian skin

SINGAPORE, June 10, 2025 /PRNewswire/ -- DR.CI:LABO™, Japan's clinic-born leading derma-cosmetics brand, unveiled new findings at IMCAS Asia 2025, reaffirming its position as the...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsDR.CI:LABO™

Bitget lists o1.exchange (O) for Spot Trading

Oma Säästöpankki Oyj:n osakkeenomistajien nimitystoimikunnan kokoonpano

Baseload Power Taiwan and CPC Corporation, Taiwan sign MOU to advance geothermal development

Tag: DR.CI:LABO™

New data from DR.CI:LABO™ at IMCAS Asia 2025 reinforces leadership in adjunctive clinical skincare for daily and post-IPL care for Asian skin

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us